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ABSTRACT Two single-nucleotide polymorphisms in the type 2 ryanodine receptor (RyR2) leading to the nonsynonymous
amino acid replacements G1885E and G1886S are associated with arrhythmogenic right ventricular cardiomyopathy in patients
who are carrying both of the corresponding RyR2 alleles. The functional properties of HEK293 cell lines isogenically expressing
RyR2 mutants associated with arrhythmogenic right ventricular cardiomyopathy, RyR2-G1885E, RyR2-G1886S, RyR2-G1886D
(mimicking a constitutively phosphorylated Ser1886), and the double mutant RyR2-G1885E/G1886S were investigated by
analyzing the intracellular Ca21 release activity resulting from store-overload-induced calcium release. The substitution of serine
forGly1886 caused a signiﬁcant increase in the cellular Ca21 oscillation activity comparedwith RyR2wild-type-expressingHEK293
cells. It was even more pronounced if glycine 1885 or 1886 was replaced by the acidic amino acids glutamate (G1885E) or
aspartate (G1886D). Surprisingly, when both substitutions were introduced in the same RyR2 subunit (RyR2-G1885E/G1886S),
the store-overload-induced calcium release activity was nearly completely abolished, although the Ca21 loading of the
intracellular stores was markedly enhanced, and the channel still displayed substantial Ca21 release on stimulation by 5 mM
caffeine. These results suggest that the adjacent glycines 1885 and 1886, located in the divergent region 3, are critical for the
function and regulation of RyR2.
INTRODUCTION
The cardiac ryanodine receptor (RyR2) located in the sar-
coplasmic reticulum (SR) membrane functions as a Ca21
release channel through which, on Ca21-induced Ca21 re-
lease, Ca21 flows from the lumen of the SR into the cyto-
plasm and activates cardiomyocyte contraction. It thus plays
a crucial role in cardiac excitation-contraction coupling (for
review see Fill and Copello (1)). The large cytoplasmic do-
main of the functional tetrameric RyR2 channel possesses the
Ca21 binding sites for initiation of Ca21-induced Ca21 re-
lease as well as binding sites for channel modulators such as
FKBP12.6, calmodulin, and ATP and target sites for phos-
phorylation by different protein kinases such as PKA, PKC,
PKG, and CaMKII (2,3). Three domains have been coarsely
defined in RyR2, the N-terminal, the central, and the C-ter-
minal domains, wheremutations leading to cardiomyopathies
including arrhythmogenic right ventricular cardiomyopathy
(ARVC) and catecholaminergic polymorphic ventricular
tachycardia have been located (4). Disease-causingmutations
in the N-terminal and central domains have been localized to
the clamp-shaped structure of RyR2 (5–7), and these muta-
tions alter the sensitivity of channel activation by luminal
Ca21 (8,9). Interaction of these two domains stabilizes the
closed state of the Ca21 release channel, and mutations in this
region might weaken this interdomain interaction, leading to
a decline of tight channel control, lowering of the barrier for
Ca21 release, and an increase in Ca21 leakage from the SR
(10). Dysfunctional RyR2 has been implicated in the gener-
ation of cardiomyopathies (for a review see Thomas et al.
(11)), and diastolic Ca21 release by a leaky cardiac Ca21
release channel is thought to be responsible for the devel-
opment of arrhythmogenesis (12).
Recently, we have identified two single-nucleotide poly-
morphisms (SNPs) in adjacent codons of the RYR2 gene
in patients suffering from ARVC that lead to the non-
synonymous amino acid exchanges G1885E and G1886S in
a composite heterozygous fashion (13). The location affected
by the mutations is part of the cardiac-specific divergent
region 3 (DR3 domain) of RyR2, which is believed to be
involved in regulation of the Ca21 release channel (6). The
combination of these two polymorphisms is associated with
ARVC in a subgroup of patients. RyR2 isolated from the
explanted heart of such an ARVC patient shows altered
channel characteristics and markedly enhanced open proba-
bility at diastolic Ca21 concentration. Because of the het-
erozygous combination of the SNPs, the actual subunit
composition of this leaky RyR2 channel is not known. The
functional channel can be either a homotetramer encoded by
either of the two alleles or a heterotetramer because of mixed
expression of both alleles. Expression of G1886Swould create
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a putative PKC phosphorylation site in RyR2, which might
confer PKC-mediatedmodulation of the Ca21 release channel.
In this work, we investigated functional properties of de-
fined RyR2 mutants related to the ARVC-associated altera-
tions G1885E and G1886S: RyR2-G1885E, RyR2-G1886S,
RyR2-G1886D mimicking a putatively phosphorylated
Ser1886, and RyR2-G1885E/G1886S with both nonsyn-
onymous amino acid exchanges in the same RyR2 subunit.
The identified SNPs were introduced into mouse RYR2
cDNA, which then was used to generate stable, inducible
HEK293 cell lines, each expressing a defined isogenic RyR2.
The store-overload-induced calcium release (SOICR) activ-
ity of these cell lines was investigated quantitatively by sin-
gle-cell Ca21 imaging and compared with the Ca21 release
behavior of RyR2 wild-type (RyR2-WT)-expressing HEK293
cells. RyR2 protein purified from these cell lines was charac-
terized biochemically, and the phosphorylation of RyR2-
G1886S was studied using the protein kinases PKA, PKG,
PKC, and CaMKII. The replacement of a glycine at the po-
sitions 1885 and 1886 of human RyR2 by an acidic residue
(G1885E, G1886D) substantially enhanced the activity of the
homotetrameric Ca21 release channel. This is true, albeit to a
lesser extent, also for G1886S, which is not a target of any of
the protein kinases investigated. Surprisingly, the double mu-
tant, G1885E/G1886S, was nearly completely inactive. This
indicates that these two positions in the RyR2 primary sequence
mark a sensitive spot in the DR3 domain that is involved in the
control of the Ca21 release properties of the channel.
EXPERIMENTAL PROCEDURES
Materials
Monoclonal RyR2 antibody (34c) was obtained from Acris Antibodies
(Hiddenhausen, Germany) FITC-labeled antimouse secondary antibody and
polyclonal anti-FKBP antibodywere fromAlexis (Lausen, Switzerland), and
peroxidase coupled antimouse and antirabbit secondary antibodies were
from MBI Fermentas (Madison, WI). Soybean phosphatidylcholine was
purchased from Avanti Polar Lipids (Alabaster, AL), CHAPS and other
reagents were from Sigma (St. Louis, MO). Activated EAH Sepharose,
N-ethyl-N9(3-dimethylamino-propyl) carbodiimid (EDC), ECL kit and hy-
perfilm were obtained from Amersham (Little Chalfont, Bucks, UK). Talon
affinity matrix was from Clontech (Mountainview, CA) and RestoreWestern
Blot Stripping Buffer from Pierce (Rockford, IL). Ca21 fluorescence indi-
cators fura-2 AM and fluo-3 AMas well as hygromycin and tetracycline were
purchased from Invitrogen (Carlsbad, CA).
Site-directed mutagenesis and DNA transfection
To generate the RyR2 mutants G1885E, G1886S, G1886D, and the double
mutant G1885E/G1886S, the corresponding SNPs were introduced into the
full-length mouse RyR2 cDNA using the overlap extension PCR method as
described by Ho et al. (14). It is of note that the sequence of the human
codons affected by the SNPs, 5653–5658, is homologous to the mouse RyR2
cDNA codon sequence 5650-5655; however, in this article, instead of the
changed nucleotide sequence, the resulting amino acid exchange corre-
sponding to the human sequence is used. The sequences of the primers used
for mutagenesis were as follows: RyR2-G1885E sense, 59-GCCAAAGA-
GGGTAAAAGGCCC-39, and antisense, 59-TTTACCCTCTTTGGCTTCT-
TCT T-39; RyR2-G1886S sense, 59-AAAGGGAGTAAAAGGCCCAAG-39,
and antisense, 59-CCTTTTACTCCCTTTGGCTTC-39; RyR2-G1886D sense,
59-AAAGGGGATAAAAGGCCCAAG-39, and antisense, 59-CCTTTTATC-
CCCTTTGGCTTC-39; RyR2-G1885E/G1886S sense, 59-GCC AAAGAGA-
GTAAAAGGCCCAAG-39, and antisense, 59-CCTTTTACTCTCTTTGGC-
TTCTT C-39. The sequences of the flanking (outer) primers were, sense,
59-AGTGAACGCCAAGGCTG G-39, and antisense, 59-AACGTACTG-
AAGTAATATGGACTT-39. The RyR2 cDNA fragments containing the
mutations were cloned back into the original position of the RyR2 cDNA se-
quence to replace the wild-type sequence. After confirmation of the mutations
by DNA sequencing, the mutated RyR2 cDNAs were used for transfection of
HEK293 cells using the Ca21 phosphate precipitation method as described in
detail by Li and Chen (15).
Generation of stable, inducible HEK293 cell lines
Flp-In TRex-293 cells (Invitrogen) were cotransfected with the inducible
expression vector pcDNA5/FRT/TO containing RyR2 wild-type or RyR2
mutant cDNA and the pOG44 vector encoding the Flp-recombinase as de-
scribed by Jiang et al. (8). Each HEK293 cell line was tested for RyR2 ex-
pression using Western blotting, immunocytofluorescent staining, and
[3H]ryanodine binding.
Single-cell Ca21 imaging
Intracellular Ca21 transients in HEK293 cells expressing wild-type and
mutant RyR2, respectively, were measured using single-cell Ca21 imaging
as described previously (8). Briefly, cells grown on glass coverslips for
20–24 h after induction by 1 mg/ml tetracycline were loaded with the fluo-
rescent Ca21 indicator dye fura-2 acetoxymethyl ester (fura-2 AM, 5 mM) in
Krebs-Ringer-Hepes (KRH) buffer (125 mM NaCl, 5 mM KCl, 1.2 mM
KH2PO4, 6 mM glucose, 1.2 mMMgCl2, 25 mMHepes, pH 7.4) plus 0.02%
pluronic F-127 (Molecular Probes, Eugene, OR) and 0.1 mg/ml BSA for
20 min at room temperature. The coverslips were mounted in a perfusion
chamber (Warner Instruments, Hamden, CT) on a Zeiss (Jena, Germany)
Axiovert 135 microscope and continuously perfused at room temperature
with KRH buffer containing increasing concentrations of CaCl2 ([Ca
21]o ¼
0, 0.1, 0.2, 0.3, 0.5, and 1.0 mM). Each of these perfusion intervals lasted for
5 min. Fura-2 fluorescence was recorded at a sampling frequency of 0.25 Hz
using a Fluor 320 objective and a Chroma filter set with the ImageMaster
System and a DeltaRAM rapid wavelength-switching illuminator (Photon
Technology International, Lawrenceville, NJ). The stored Ca21 of HEK293
cells expressing the various RyR2 was assessed after the final perfusion with
1mMCa21 by a challengewith 5mMcaffeine inKRHcontaining 1mMCa21.
The recorded fura-2 fluorescence traces were analyzed using a computer
program written in MATLAB. Only those traces that contain at least one
fluorescence value greater than two times the median fluorescence value
during the perfusion with Ca21-free KRH were considered for analysis
of intracellular Ca21 release. This excludes those stably RyR2-transfected
HEK293 cells that do not respond to caffeine with a substantial Ca21 release
from their internal stores. Furthermore, cells showing fluorescence traces
with minimal (one time point) or prolonged threshold crossings (.5 time
points) were individually inspected and rejected from further analysis in case
of untypical Ca21 transients. Traces with large amplitudes (fura-2 ratios of 6–
8) were inspected and treated as indicated. Traces with larger ratios (.8)
were eliminated. The relation between Ca21 oscillation frequency and
[Ca21]o of individual cells was determined from the number of threshold
crossings within the time interval corresponding to a given [Ca21]o.
Analysis of the [Ca21]o-dependent Ca
21
oscillation behavior of RyR2-expressing
HEK293 cells
The Ca21 oscillation frequency of different RyR2-expressing HEK293 cell
lines changes with the extracellular Ca21 concentration [Ca21]o. If, for a
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specific RyR2-expressing HEK293 cell line, Nðf Þ denotes the number of
cells oscillating with a certain frequency f ; and N is the total number of
oscillating cells, the relative number of cells obeying certain discrete Ca21
oscillation frequencies f ¼ 0; 0:2; 0:4; . . . ; fmax (min1)—determined by the
number of Ca21 transients during a 5-min [Ca21]o interval—is given by
pð f Þ ¼ Nð f Þ=N: With increasing [Ca21]o, the bandwidth i of the observed
discrete frequencies f1; . . . ; fi increases. For all [Ca
21]o, the relative number
of oscillating cells, cumulatively summed up over the whole observed fre-
quency bandwidth, will approach 1 with increasing oscillation frequency. This
cumulative relative oscillation frequency distribution (CROFD) is given by
qð f Þ ¼ +
i
ðpð fiÞÞ; with f1 ¼ 0min1 and lim
f/fmax
ðqð f ÞÞ ¼ 1:
(1)
For all [Ca21]o used, the CROFD obtained can well be described by the
empirical function
qð f Þ ¼ q01 ð1 q0Þ3 ðg3 f Þn=ð11 ðg3 f ÞnÞ (2)
with q ¼ q0 for f ¼ 0 and q ¼ 1 for f  1=g: The characteristic parameters
q0; g; and n were obtained from fits to the CROFD measured at [Ca
21]o of
0 to 1 mM. According to the experimental results obtained, g and q0 are
[Ca21]o-dependent parameters that can be approximated by the functions
gð½Ca21 0Þ ¼ g0  h3 ½Ca21 0 (3)
q0ð½Ca21 0Þ ¼ 1 ð½Ca21 0=KSÞm=ð11 ð½Ca21 0=KSÞmÞ;
(4)
the parameters of which were determined by fits to the measured data. The
relative number of cells oscillating at a given [Ca21]o with a frequency
bandwidth f1; . . . ; fi can be obtained from the CROFD by
pð fj; ½Ca21 0Þ ¼ qð fj; ½Ca21 0Þqð fj1; ½Ca21 0Þ; j¼ 2; . . . ; i
(5)
and p f1; ½Ca210
  ¼ q f1; ½Ca210
 
: Equations 2 and 5 together with the
obtained fit parameters describe relative oscillation frequency distributions
up to a limiting ½Ca21lim0 ¼ g0=h: The image recording frequency used of
15 frames/min was three times the maximum observed Ca21 oscillation
frequency (;5 min1) and thus sufficient to exclude limitations by the
recording process.
Generation and puriﬁcation of phosphorylation
state- and site-speciﬁc anti-RyR2 antibodies
The individually designed polyclonal antisera and the synthetic peptides
corresponding to the sequences of the mouse RyR2 were obtained from
NeoMPS (Strasbourg, France). The following phosphopeptides and non-
phosphopeptides were constructed: H1-GGAKGS(PO3)KRPK-AHX-Y-OH
(pSer-1886) and H1-GGAKGSKRPK-AHX-Y-OH (Ser-1886). These are
unique among the known phosphopeptide sequences, and they are typical for
RyR2 according to a BLASTP2.2.5 database search. To generate antibodies
to the two peptides, two rabbits each were immunized with the above pep-
tides covalently coupled to ovalbumin. IgG fractions were obtained after
ammonium sulfate precipitation according to Javois (16) and subjected to
affinity chromatography over carbodiimid-activated EAH Sepharose 4B
(Amersham Biosciences) coupled with phosphopeptides and nonphos-
phopeptides according to manufacturer’s instructions. The columns were
reused several times and stored in water at 4C. To obtain the phosphospe-
cific antibodies and to eliminate the nonphospho- and nonspecific antibodies,
the IgG fraction was first applied to the nonphosphopeptide affinity column.
The breakthrough containing phosphopeptide antibodies obtained by
washing the column with BBS buffer was applied to the phosphopeptide
affinity column. Phosphopeptide antibodies were eluted with 0.1 M glycine,
0.5 M NaCl, pH 2.7, into tubes containing NaOH to neutralize the pH.
Nonphosphopeptide antibodies were purified analogously by first applying
the IgG fraction to a column prebound with the phosphopeptide. The re-
sulting flowthrough was then applied to the nonphosphopeptide affinity
column. Immunoreactivity and -specificity of the affinity-purified phospho-
and nonphosphopeptide antibodies were determined by means of ELISA.
Preimmune sera showed no immunoreactivity.
Human recombinant FKBP12.6
The plasmid construct for the expression of the N-terminal polyhistidine-
tagged FKBP12.6 fusion protein was generated using the TOPO-TA cloning
kit (Invitrogen). As template for amplification, a human brain total cDNA
(Clontech) was used with the following primers: sense, 59-ATGGGCGTG-
GAGATCGAGACCATC-39, and antisense, 59-TCACTCTAAGTTGAG-
CAG CTCCACGTC-39. After amplification, the PCR product was ligated
into the expression vector pCRT7/NT TOPO (Invitrogen), and the sequence
of the cloned construct was confirmed by DNA sequencing. After transfor-
mation of chemical competent BL21(DE3) E. coli, protein overexpression
was induced by 0.4 mM isopropyl-b-thiogalactopyranoside. The recombi-
nant polyhistidine-tagged FKBP12.6 fusion protein was obtained from the
supernatant of the cell homogenate by means of affinity chromatography
columns (Protino Ni-Ted kit, Macherey-Nagel, Du¨ren, Germany).
Preparation of cell lysate, solubilization, and
enrichment of the expressed RyR2 and
ryanodine binding assay
Cell lysates were obtained from stable, inducible HEK293 cells grown for
various durations after induction by 1 mg/ml tetracycline as described in
detail by Kong et al. (17). Recombinant RyR2 proteins were further enriched
either by sucrose density gradient centrifugation (7–25% w/v) for 16 h at
100,0003 g (13) or by affinity chromatography using Talon Affinity matrix
(Clontech) prebound with purified 300 mg His-tagged FKBP12.6 fusion
protein for 18 h at 4C.After sedimentation andwashingwith PBS buffer, the
sediment containing the RyR2-FKBP12.6 complex-bound beads was used
directly as substrate in phosphorylation assays. The binding of RyR2 to the
FKBP12.6-loaded matrix was confirmed by SDS-PAGE and Western blot-
ting after elution of the RyR2-FKBP12.6 complex from the beads by SDS
sample buffer. [3H]Ryanodine binding assays were carried out with different
RyR2 variants as described by Jiang et al. (9).
Phosphorylation of Ser1886 in RyR2-G1886S by
various protein kinases
Recombinant RyR2 obtained in different ways was used as a substrate for
protein kinases previously activity-optimized with model peptides and pro-
teins, respectively, according to the instructions provided by the suppliers.
PKA catalytic subunit was a generous gift from Dr. Friedrich Herberg,
Universita¨t Kassel, Germany. Recombinant PKGwas purchased fromAlexis
(Lausen, Switzerland), catalytic subunit of native PKC of rat brain was ob-
tained from Calbiochem (La Jolla, CA), and recombinant CaMKII was from
New England Biolabs (Ipswich, MA). RyR2 in the following states of purity
were used: RyR2 in cell lysate, enriched by sucrose gradient centrifugation,
or purified by affinity chromatography over FKBP12.6-bound Talon
Sepharose beads. Phosphorylation by catalytic subunit of PKA was carried
out in a buffer containing 10 mM MOPS, pH 7.0, 200 mM KCl, 1.5 mM
DTT, 0.5 mM [g-32P]ATP, and 50 nM ocadaic acid.
Statistical evaluation
Mean values are presented as mean6 SE, and statistical comparison of data
corresponding to the different RyR2 was carried out using one-way ANOVA
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with Tukey’s posttest. An error probability p , 0.05 was considered sig-
nificant and is indicated where applicable.
RESULTS
Construction and generation of stable, inducible
HEK293 cell lines expressing RyR2-WT,
RyR2-G1885E, RyR2-G1886S, RyR2-G1886D,
and RyR2-G1885E/G1886S
We have previously shown that a composite heterozygous
SNP combination leading to the nonsynonymous exchanges
G1885E and G1886S in the human RyR2 1), is associated
with ARVC, 2), leads to a substantially increased diastolic
open probability of RyR2 from a terminally failing heart of
such a patient, and 3), may contain a PKC phosphorylation
site created by one of the mutations, G1886S (13). The actual
tetrameric subunit combination(s) of the functional RyR2
in human hearts of this RyR2 genotype is not known. Two
possible compositions resulting from homozygous combi-
nations are given by RyR2-G1885E and RyR2-G1886S, re-
spectively, which were recombinantly generated. The latter
represents the homotetramer with the suggested putative
PKC phosphorylation site.
Stable, inducible HEK293 cell lines expressing the ARVC-
related RyR2 mutants G1885E and G1886S were generated
according to the method of Jiang et al. (8). Additionally, a cell
line that stably expresses RyR2-G1886D, mimicking a con-
stitutively phosphorylated Ser1886, and a further one with both
mutations in a single RyR2 subunit (RyR2-G1885E/G1886S)
were established. The functional properties of these RyR2
variants were studied by measuring the SOICR activity of the
RyR2-expressing HEK293 cells and by phosphorylation as-
says using purified RyR2-G1886S as a substrate for the protein
kinases PKC, PKA, PKG, and CaMKII.
The expression of the variant RyR2 proteins in HEK293
cell lines was confirmed by immunofluorescent staining (Fig.
1, A–F) and Western blotting (Fig. 1 G) using monoclonal
RyR2 antibody. This antibody detected a high-molecular-
weight band in the HEK293 cell lines expressing RyR2 (Fig.
1, B–G) but not in the parental cells transfected with the
control vector DNA (Fig. 1 A).
Biochemical characterization of the different
RyR2 mutants
To determine whether the expressed RyR2-WT, RyR2-
G1885E, RyR2-G1886S, RyR2-G1886D, and RyR2-G1885E/
G1886S, respectively, function as Ca21 release channels,
we measured intracellular Ca21 release in HEK293 cells
expressing the various RyR2 forms using the fluorescent
Ca21 indicator dye fluo-3 acetoxymethyl ester. As shown in
Fig. 2 A, all RyR2-expressing HEK293 cell lines displayed
comparable Ca21 transients in response to repeated stimu-
lation by caffeine, a well-known activator of RyR2. The
normalized caffeine dose-response curves obtained from the
traces shown in Fig. 2 A were similar for RyR2-WT, RyR2-
G1885E, RyR2-G1886S, and RyR2-G1886D, with half-
maximum responses in the range of 0.11–0.20 mM caffeine
(Fig. 2 B). For RyR2-G1885E/G1886S the half-maximum
response was observed at 0.40 mM caffeine. Because the
caffeine activation procedure was the same for all cell lines,
these data suggest that the doubly mutated RyR2 is relatively
less sensitive to caffeine than the other RyR2 variants (p ,
0.001). The Ca21-dependent [3H]ryanodine binding to the
different RyR2 (Fig. 2 D) reaches half-saturation at about the
same Ca21 concentration but rises with a markedly reduced
Ca21 cooperativity in case of RyR2-G1885E/G1886S com-
pared with the other RyR2 variants (p, 0.001). On the other
hand, the well-known suppression (18) of the caffeine-
induced Ca21 release by ryanodine (Fig. 2 C, b and c) after it
has gained access to the open state of the channel induced by
FIGURE 1 Immunofluorescent staining (A–F) and West-
ern blot analysis (G) of stable, inducible HEK293 cell lines
expressing RyR2-WT (B), RyR2-G1886S (C), RyR2-
G1886D (D), RyR2-G1885E (E), and RyR2-G1885E/
G1886S (F), respectively. (A–F) Stable, inducible
HEK293 cells expressing the different RyR2 (B–F) as
well as parental HEK293 cells transfected with empty
expression vector pcDNA5/FRT/TO (A) were fixed and
permeabilized 24 h after induction by tetracycline. RyR2
proteins were detected using monoclonal RyR2 antibody
and secondary FITC-conjugated antimouse IgG antibody
(scale bar, 20 mm). (G) Cell lysates were prepared from the
HEK293 cell lines shown in B to F. RyR2 proteins were
separated by SDS-PAGE and immunoblotted with RyR2
antibody and secondary HRP-coupled antimouse IgG anti-
body.
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caffeine (Fig. 2 C, a) is well preserved for all the expressed
RyR2 variants. These data indicate comparable, wild-type-
like channel function for the mutants RyR2-G1885E, RyR2-
G1886S, and RyR2-G1886D and altered channel properties
for the double mutant RyR2-G1885E/G1886S.
Phosphorylation of Ser1886 in RyR2-G1886S
The phosphorylation of Ser1886, which is a putative PKC
phosphorylation site in the RyR2 mutant G1886S (13), was
investigated using recombinant RyR2-G1886S protein of
different purification states as a substrate for PKC and other
protein kinases, PKA, PKG, and CaMKII, known to phos-
phorylate RyR2 (for review see Meissner (3) and Xiao et al.
(19)). The substrate was presented in three different purifi-
cation grades: RyR2-G1886S in crude cell lysate (Fig. 3 A),
RyR2-G1886S bound to FKBP12.6-coupled Sepharose
beads (Fig. 3 B), and RyR2-G1886S highly enriched by su-
crose density centrifugation (Fig. 3 C). All tested kinases
phosphorylate the mutant channel protein (row 4). Phos-
phorylation of RyR2 at Ser1886 by these kinases was studied
by means of sequence-specific antibodies that selectively
recognize either the phosphorylated (phosphopeptide anti-
bodies) or the nonphosphorylated serine residue (non-
phosphopeptide antibodies). The phosphopeptide antibodies
did not identify a phosphorylated serine residue (row 2), al-
though sufficient amounts of substrate protein were available
for all kinases (rows 3 and 4). Accordingly, nonphos-
phorylated Ser1886 was detected by nonphosphopeptide an-
tibodies in this mutant RyR2 presented in different degrees of
purity (row 1). Thus, the mutation-created Ser1886 is unlikely
to be a target of any of the tested kinases.
SOICR in HEK293 cells expressing different
RyR2 mutants
Single-cell Ca21 imaging experiments with the stable, in-
ducible HEK293 cell lines were carried out to assess their
SOICR properties as described by Jiang et al. (8). These
RyR2 expressing HEK293 cells are all sensitive to caffeine
applied at the end of an experiment (Fig. 4, left and right
panels). They also, with the notable exception of HEK
cells expressing RyR2-G1885E/G1886S, readily developed
SOICR activity when perfused with increasing [Ca21]o. This
leads to a time domain filled with Ca21 transients before the
final activation by 5 mM caffeine (Fig. 4, middle panel). In
the experiment shown in Fig. 4, ;40–70% of the caffeine-
sensitive HEK293 cells expressing RyR2-WT (41%), RyR2-
G1885E (68%), RyR2-G1886S (49%), and RyR2-G1886D
(59%), respectively, exhibited substantial SOICR (Fig. 4,
A–D). In contrast, of a comparable number of 264 caffeine-
responsive HEK293 cells expressing RyR2-G1885E/G1886S,
only three (1%) showed significant Ca21 release activity
(Fig. 4 E). This markedly different SOICR behavior is
summarized in Fig. 5 on the basis of four independent ex-
periments. The number of cells showing SOICR compared
with the total number of caffeine-responsive cells rises sig-
moidally with increasing [Ca21]o for all RyR2 variants ex-
pressed (Fig. 5 A). So did the average number of Ca21
transients per caffeine-responsive cell (Fig. 5 B) as well as the
FIGURE 2 Fluo-3 fluorescence of HEK293 cells
(A–C) expressing RyR2-WT, RyR2-G1886S, RyR2-
G1886D, RyR2-G1885E, and RyR2-G1885E/
G1886S, respectively, in response to caffeine (A,
B, C) and ryanodine (C) and Ca21-dependent
ryanodine binding to the different RyR2 mutants
(D). The traces and curves shown are color coded:
RyR2-WT (black); RyR2-G1886S (red); RyR2-
G1886D (green); RyR2-G1885E (blue); RyR2-
G1885E/G1886S (magenta). (A) Fluorescence
signals of cells expressing a specific RyR2 variant
in response to successive additions of caffeine
(mM): 0.025, 0.05, 0.1, 0.25, 0.5, 1, 2.5, and 5.
The first addition is marked by an arrow, and the
following ones can be identified by the induced
Ca21 transients. (B) Caffeine-induced Ca21 tran-
sient amplitude as function of the applied caffeine
concentration normalized to the maximum response
obtained at 1 mM caffeine. The datasets (n ¼ 4) are
approximated by a sigmoidal function of the type
y ¼ xh/(KDh 1 xh). (C) Blockage of the expressed
RyR2 variants by 100 mM ryanodine. After an
initial stimulation with 0.25 mM caffeine ( first peak) followed by the ryanodine addition (arrow), the cells are challenged by three successive additions of
2.5 mM caffeine (a, b, and c). (D) Ca21-dependent ryanodine binding to the RyR2 variants. Lysates (30 ml) prepared from the RyR2-expressing cell lines were
incubated with 5 nM [3H]ryanodine. The datasets are approximated by the sigmoidal function given above. The Ca21 concentrations at half-maximum
ryanodine binding, KD, and Hill coefficients, h, are 165 6 3 nM and 3.08 6 0.21 (n ¼ 6) for RyR2-WT, 163 6 6 nM and 2.36 6 0.23 (n ¼ 6) for RyR2-
G1886S, 1796 6 nM and 1.936 0.13 (n¼ 6) for RyR2-G1886D, 1686 5 nM and 2.166 0.15 (n¼ 6) for RyR2-G1885E, and 1176 27 nM and 0.456 0.06
(n ¼ 5) for RyR2-G1885E/G1886S.
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average number of Ca21 transients per Ca21-oscillating cell
(Fig. 5 C). Because of the very low number of oscillatory
active HEK293 cells expressing RyR2-G1885E/G1886S,
reliable fits to the data could not easily be obtained in this
case. Nevertheless, it is obvious that, on average, these cells
are much less Ca21 oscillating (Fig. 5, A and B) and, if so,
show far fewer Ca21 transients per active cell at a given
[Ca21]o (Fig. 5 C) than the other RyR2-expressing cell lines.
The data shown in Fig. 5 also suggest more subtle differences
among these latter RyR2 variants, especially for RyR2-
G1885E and -G1886D compared with RyR2-WT and
-G1886S. A detailed analysis of the Ca21-oscillating be-
havior of individual cells of the different RyR2-expressing
cell lines reveals essentially the same results (data not
shown). The comparison of the [Ca21]o-dependent SOICR
activity of these cells isogenically expressing a defined RyR2
yields the following sequence of RyR2 channel activity:
RyR2-G1886DRyR2-G1885E.RyR2-G1886S
.RyR2-WT
RyR2-G1885E=G1886S:
In case of the double mutant RyR2-G1885E/G1886S,
SOICR is nearly completely abolished.
Store Ca21 load and Ca21 transient amplitudes
during SOICR activity
To determine whether the Ca21 loading of the intracellular
Ca21 store is different or is changed differently during the
single-cell Ca21-imaging experiments, the Ca21 transients
induced by 5 mM caffeine at the end of an experiment were
compared among the different cell lines (Fig. 6 A). The am-
plitude of this transient, which reflects the Ca21 loading of
the store after a preceding history of SOICR, is similar for
RyR2-WT, RyR2-G1886S, RyR2-G1886D, and RyR2-
G1885E but strongly enhanced for RyR2-G1885E/G1886S
(Fig. 6 A, white bars). This observation is in agreement with
the [Ca21]o-dependent SOICR activity described above, in-
dicating that a substantial SOICR activity, as observed with
HEK293 cells expressing the former RyR2 variants, is ac-
companied with a reduced steady-state Ca21 loading of
the internal store and a reduced threshold for SOICR. This
interpretation is supported by the finding that caffeine-
responsive HEK293 cells, which are not Ca21-oscillating
during the perfusion with increasing [Ca21]o, tend to respond
to the caffeine challenge with enhanced Ca21 transient
amplitudes, reaching those of the barely Ca21-oscillating
HEK293 cells expressing RyR2-G1885E/G1886S (Fig. 6 A,
gray bars). The amplitudes of the SOICR events during the
Ca21 perfusion period were very similar for HEK293 cells
expressing RyR2-WT, RyR2-G1886S, RyR2-G1886D, and
RyR2-G1885E, respectively (Fig. 6 B). They reached;70%
of the final caffeine-induced Ca21 transient amplitude inde-
pendent of the actual [Ca21]o. This indicates that for these
RyR2-expressing cells, the individual SOICR event is a well-
controlled process that always gives rise to a uniform Ca21
transient. In case of the HEK293 cells expressing RyR2-
G1885E/G1886S, the Ca21 transient amplitude at 0.5 and
1 mM [Ca21]o reaches ;60% of the final caffeine-induced
Ca21 transient amplitude and drops to 30–40% at [Ca21]o,
0.5 mM. This indicates that here SOICR has not yet reached a
consistent steady state during the [Ca21]o perfusion period
and thus depends on the interplay between the actual state of
Ca21 store and that of the Ca21 release channel, especially at
lower [Ca21]o.
DISCUSSION
The amino acid exchanges G1885E and G1886S investigated
here, which are caused by ARVC-associated SNPs (13), are
FIGURE 3 Phosphorylation of Ser1886 in RyR2-G1886S
by various protein kinases. Three different types of RyR2-
G1886S preparation were used as substrate for PKA, PKC,
PKG, and CaMKII as indicated in the figure: (A) RyR2 in
HEK293 cell lysate, (B) RyR2 immobilized to FKBP12.6-
coupled beads, and (C) RyR2 enriched by sucrose density
gradient centrifugation. After separation by SDS-PAGE,
the proteins were immunoblotted with antibody against
RyR2 (row 3), sequence-specific antibodies against a
Ser1886-containing peptide reflecting the potential RyR2
phosphorylation site (nonphosphopeptide antibody, row 1),
and corresponding antibodies against a Ser1886(PO3)-
containing peptide (phosphopeptide antibody, row 2).
Autoradiographs (row 4) demonstrate the phosphorylation
of RyR2-G1886S by all of the protein kinases applied, but
Ser1886 is no substrate of one of these tested kinases
(compare rows 1 and 2).
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FIGURE 4 Single-cell fura-2 fluorescence recordings of HEK293 cells stably expressing RyR2-WT (A), RyR2-G1886S (B), RyR2-G1886D (C), RyR2-
G1885E (D), and RyR2-G1885E/G1886S (E), respectively. The cells were successively incubated at increasing external Ca21 concentrations, [Ca21]o ¼ 0,
0.1, 0.2, 0.3, 0.5, and 1.0 mM (5 min for each incubation period), followed by a final challenge with 5 mM caffeine in presence of 1.0 mM [Ca21]o. (Left panel)
Cells that are responsive to 5 mM caffeine added at the end of an experiment. Only these caffeine-responsive cells were subjected to further analysis of their
Ca21 oscillation behavior before this final challenge. They amount to 78, 281, 291, 286, and 264 cells (A–E) and may exhibit nontypical Ca21 transients or no
spontaneous Ca21 transient at all before the caffeine treatment (see Experimental Procedures). (Middle panel) Truly Ca21-oscillating cells obtained after
analyzing all individual traces shown in the left-hand panel. The numbers of cells remaining after this selection are 32, 137, 171, 195, and 3 cells (A–E). (Right
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located in the divergent region 3 of RyR2 that is specific for
cardiac muscle. This DR3 domain comprises residues 1852–
1890 of RyR2 (6) and has been mapped to domain 9 in the
clamp structure of RyR2 (20). The two glycine residues af-
fected by the SNPs lay adjacent to the FKBP12.6 binding
site, which recently has been assigned to the residues 1636–
1937 (21). Because of the heterozygous combination of the
two SNPs associated with ARVC in a subgroup of patients
(13), carriers of this RyR2 genotype are not expressing wild-
type RyR2 but RyR2 subunits that contain the amino acid
exchange G1885E or G1886S in either a sole or combined
fashion. In the study presented here, we have investigated
homotetrameric RyR2 composed of subunits with either
Glu1885 or Ser1886 in the DR3 domain, which reflect the
former of the two possibilities mentioned before. A coex-
FIGURE 4 (Continued).
panel) Typical spontaneous Ca21 transients of the cells shown in the middle panel. The horizontal lines indicate the individual thresholds used for definition of
a SOICR event (see Experimental Procedures). The vertical green lines mark the 5-min time intervals that correspond to successively increasing [Ca21]o. In the
final interval marked by the red line, the cells were challenged with 5 mM caffeine in addition to 1 mM [Ca21]o. The bar under A defines the color code used in
the three-dimensional representations of the Fura-2 ratio levels.
FIGURE 5 On average [Ca21]o-dependent Ca
21-oscillation behavior of
HEK293 cells expressing a specific RyR2 variant. Shown are total mean 6
SE of four independent experiments comprising several hundred cells for
each RyR2-expressing cell line: RyR2-WT (black), RyR2-G1886S (red),
RyR2-G1886D (green), RyR2-G1885E (blue), and RyR2-G1885E/G1886S
(magenta). (A) Number of cells exhibiting spontaneous Ca21 transients
relative to the number of caffeine-responsive cells. (B) Average number of
Ca21 transients per caffeine-responsive cell. (C) Average number of Ca21
transients per Ca21-oscillating cell.
FIGURE 6 Amplitudes of caffeine-induced (A) and [Ca21]o-dependent
spontaneous Ca21 transients (B) of HEK293 cells expressing different
RyR2. Shown are Fura-2 ratios (total mean 6 SE) of four independent
experiments with RyR2-WT, RyR2-G1886S, RyR2-G1886D, RyR2-
G1885E, and RyR2-G1885E/G1886S (colors in B: black, red, green, blue,
and magenta, respectively). (A) Amplitudes of Ca21 transients induced by 5
mM caffeine at the end of an experiment with HEK293 cells either showing
(white bars; based on 200 to 690 cells for RyR2-WT, RyR2-G1885E, RyR2-
G1886S, and RyR2-G1886D, and 19 cells for RyR2-G1885E/G1886S) or
not showing (gray bars; several hundred cells in each case) spontaneous
Ca21 transients before the caffeine challenge. (B) Mean amplitudes of
spontaneous Ca21 transients observed in the [Ca21]o range indicated relative
to the amplitude of the corresponding caffeine-induced Ca21 transient
obtained at the end of an experiment. The values for RyR2-G1885E/G1886S
are based on nine oscillating cells, whereas those of all the other RyR2
variants were derived from a couple of hundred oscillating cells.
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pression of both RyR2 mutants in a single cell, which would
reflect the second possibility, seems hardly possible consid-
ering the size of the gene, and even if successful, the actual
subunit composition of the resulting functional RyR2 chan-
nel would not be known.
Expression of G1886S enabled us to study the phospho-
rylation of the putative PKC phosphorylation site introduced
into RyR2 by one of the SNPs. The results show that RyR2-
G1886S is a substrate of the protein kinases PKA, PKC,
PKG, and CaMKII which are known to phosphorylate RyR2
(for review seeMeissner (3)), but Ser1886 is not a target of any
of these kinases used. This result refocuses attention from
posttranslational modification back to the amino acid ex-
change itself at the position 1886 of RyR2. We have studied
[Ca21]o-dependent SOICR activity of HEK293 cells iso-
genically expressing the corresponding RyR2. Expression of
RyR2-G1886S in comparison to RyR2-WT leads to a sig-
nificant increase in the SOICR activity of the corresponding
cells, which in turn indicates an enhanced RyR2 channel
activity as a result of this mutation. The effect is even more
pronounced for the mutation G1885E, which introduces an
acidic residue into the DR3 domain in substitution of glycine.
A similar enhanced SOICR activity was observed with
HEK293 cells expressing RyR2-G1886D, initially included
in the study to mimic a mutated RyR2 constitutively phos-
phorylated at Ser1886. The effects of these two mutations,
which both lead to replacement of glycine by an acidic amino
acid at the positions 1885 and 1886, respectively, in the DR3
domain, are very similar. The DR3 region lies adjacent to the
FKBP12.6 binding site of RyR2 and seems to be involved in
the regulation of the Ca21 release channel by physiological
modulators such as ATP and Mg21 (6). It is part of a cluster
of domains of the RyR2 that undergo conformational change
when the channel is switched from the closed to the open state
(22,23). According to the results presented here, the glycine
residues 1885 and 1886 represent a critical spot in the DR3
domain, which when replaced, especially by an acidic amino
acid, lead to a destabilization of the channel reflected by in-
creased SOICR activity at the cellular level and increased di-
astolic open probability at the single-channel level shown
previously (13). It should be emphazised again, with respect to
the composite heterozygous RyR2 genotype associated with
ARVC (13), that carriers of this genotype could express singly
mutated RyR2-G1885E and RyR2-G1886S in homotetra-
meric or heterotetrameric combinations. The homotetrameric
RyR2 composed of either RyR2-G1885E or RyR2-G1886S
studied here could be responsible for the enhanced lowest
subconductance state of the Ca21 release channel observed
(13). But, according to the results presented here, tetramers
composed of both singly mutated RyR2 types will presumably
lead to a phenotype intermediate between a strongly destabi-
lized RyR2-G1885E and a mildly destabilized RyR2-G1886S
and thus to channel leakiness compared with wild-type RyR2.
It is very surprising that, when both mutations, G1885E
and G1886S, each of which tends to induce enhanced chan-
nel activity, are combined in a single RyR2 subunit, RyR2-
G1885E/G1886S, the channel activity is strongly inhibited.
The characteristic blocking of the Ca21 release channel in a
closed state by 100 mM ryanodine was apparently preserved
in this RyR2 mutant, but the Ca21-dependent ryanodine
binding was significantly changed compared with the other
RyR2 types studied. The sensitivity of RyR2-G1885E/
G1886S to caffeine was significantly reduced, but the chan-
nel activation by 5 mM caffeine led to a typical substantial
intracellular Ca21 release in HEK293 cells expressing this
doubly mutated RyR2. At the same time, the spontaneous
SOICR activity of these cells was nearly completely blocked
despite the fact that the Ca21 loading of the intracellular store
was rather increased. Thus, the combination in the same
RyR2 subunit of the Ca21 release-supporting amino acid
exchange G1886S with the strongly Ca21 release-promoting
mutation G1885E surprisingly leads to a nearly complete
shutdown of the spontaneous SOICR activity. It seems that
the Ser1886 adjacent to Glu1885 stabilizes the Ca21 release
channel even above the level present in the wild-type RyR2.
These results indicate that the residues 1885 and 1886 of
RyR2 mark a sensitive spot inside the DR3 domain that is
important for the control of the Ca21 release properties of
the channel. Because we were studying recombinant RyR2
expressed in HEK293 cells, the observed effects are caused
solely by a direct modification of the channel protein itself.
Whether the changes in the critical spot of the DR3 domain
induced by the mutations might affect the FKBP12.6
binding site adjacent to the DR3 domain remains to be
studied.
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